Antioxidant and anti-inflammatory effects of selenium in oral buccal mucosa and small intestinal mucosa during intestinal ischemia-reperfusion injury

Journal of Inflammation (United Kingdom)

Volumn 11, Issue 1, 2014, Pages

  Kim, Yongsoo ^a   Kim, Dong Chil ^a   Cho, Eui Sic ^a   Ko, Seung O ^a   Kwon, Woon Yong ^b   Suh, Gil Joon ^b   Shin, Hyo Keun ^a  

^a Chonbuk National University Medical School   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

Buccal mucosa; Ischemia reperfusion injury; Lipid peroxidation; NF kappaB; Selenium; Small intestine

Indexed keywords

GLUTATHIONE PEROXIDASE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; SELENIUM; TRANSCRIPTION FACTOR RELA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; INTESTINE INJURY; INTESTINE ISCHEMIA; LIPID PEROXIDATION; NONHUMAN; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REPERFUSION INJURY;

EID: 84920762097     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/s12950-014-0036-1     Document Type: Article

References (38)

1. Stallion A, Kou TD, Miller KA, Dahms BB, Dudgeon DL, Levine AD: IL-10 is not protective in intestinal ischemia reperfusion injury. J Surg Res 2002, 105:145-152.
2. Carden DL, Granger DN: Pathophysiology of ischaemia reperfusion injury. J Pathol 2000, 190:255-266.
3. Yamamoto S, Tanabe M, Wakabayashi G, Shimazu M, Matsumoto K, Kitajima M: The role of tumor necrosis factor-alpha and interleukin-1 beta in ischemia-reperfusion injury of the rat small intestine. J Surg Res 2001, 9:134-141.
4. Ceppa EP, Fuh KC, Bulkley GB: Mesenteric hemodynamic response to circulatory shock. Curr Opin Crit Care 2003, 9:127-132.
5. Pantano C, Reynaert NL, van der Vliet A, Janssen-Heininger YM: Redoxsensitive kinases of the nuclear factor-kappaB signaling pathway. Antioxid Redox Signal 2006, 8:1791-1806.
6. Gloire G, Piette J: Redox regulation of nuclear post-translational modifications during NF-kappaB activation. Antioxid Redox Signal 2009, 11:2209-2222.
7. Yao H, Yang SR, Kode A, Rajendrasozhan S, Caito S, Adenuga D, Henry R, Edirisinghe I, Rahman I: Redox regulation of lung inflammation: role of NADPH oxidase and NF-kappaB signalling. Biochem Soc Trans 2007, 35:1151-1155.
8. Kretz-Remy C, Arrigo AP: Selenium: a key element that controls NF-kappa B activation and I kappa B alpha half life. Biofactors 2001, 14:117-125.
9. Maehira F, Miyagi I, Eguchi Y: Selenium regulates transcription factor NF-kappaB activation during the acute phase reaction. Clin Chim Acta 2003, 334:163-171.
10. Shenkin A: Selenium in intravenous nutrition. Gastroenterology 2009, 137:S61-S69.
11. Cheng W, Fu YX, Porres JM, Ross DA, Lei XG: Seleniumdependent cellular glutathione peroxidase protects mice against a pro-oxidant-induced oxidation of NADPH, NADH, lipids, and protein. FASEB J 1999, 13:1467-1475.
12. Kim KS, Suh GJ, Kwon WY, Kwak YH, Lee K, Lee HJ, Jeong KY, Lee MW: Antioxidant effects of selenium on lung injury in paraquat intoxicated rats. Clin Toxicol 2012, 50:749-753.
13. Ostadalova I, Vobecky M, Chvojkova Z, Mikova D, Hampl V, Wilhelm J, Ostadal B: Selenium protects the immature rat heart against ischemia/ reperfusion injury. Mol Cell Biochem 2007, 300:259-267.
14. Ozbal S, Erbil G, Koçdor H, Tugyan K, Pekçetin C, Ozogul C: The effects of selenium against cerebral ischemia-reperfusion injury in rats. Neurosci Lett 2008, 438:265-269.
15. Sakr Y, Reinhart K, Bloos F, Marx G, Russwurm S, Bauer M, Brunkhorst F: Time course and relationship between plasma selenium concentrations, systemic inflammatory response, sepsis, and multiorgan failure. Br J Anaesth 2007, 98:775-784.
16. Angstwurm MW, Engelmann L, Zimmermann T, Lehmann C, Spes CH, Abel P, Strauss R, Meier-Hellmann A, Insel R, Radke J, Schüttler J, Gärtner R: Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Crit Care Med 2007, 35:118-126.
17. Sonis ST: A biological approach to mucositis. J Support Oncol 2004, 2:21-32.
18. De Backer D, Creteur J, Preiser JC, Dubois MJ, Vincent JL: Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med 2002, 166:98-104.
19. Elbers PW, Ince C: Mechanism of critical illness-classifying microcirculating flow abnormalities in distributive shock. Crit Care 2006, 10:221.
20. Kim SI, Kim YB, Koh KM, Youn YK, Suh GJ, Cho ES, Leem DH, Baek JA, Shin HK, Ko SO: Activation of NF-kB pathway in oral buccal mucosa during small intestinal ischemia-reperfusion injury. J Surg Res 2013, 179:99-105.
21. Ganji SH, Qin S, Zhang L, Kamanna VS, Kashyap ML: Niacin inhibits vascular oxidative stress, redox-sensitive genes, and monocyte adhesion to human aortic endothelial cells. Atherosclerosis 2009, 202:68-75.
22. Lee J, Kwon W, Jo Y, Suh G, Youn Y: Protective effects of ethyl pyruvate treatment on paraquat-intoxicated rats. Hum Exp Toxicol 2008, 27:49-54.
23. Ohkawa H, Ohishi N, Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979, 95:351-358.
24. Martins JO, Zanoni FL, Martins DO, Coimbra R, Krieger JE, Jancar S, Sannomiya P: Insulin regulates cytokines and intercellular adhesion molecule-1 gene expression through nuclear factor-kappaB activation in LPS-induced acute lung injury in rats. Shock 2009, 31:404-409.
25. Kwon WY, Suh GJ, Kim KS, Jo YH, Lee JH, Kim K, Jung SK: Glutamine attenuates acute lung injury by inhibition of high mobility group box protein-1 expression during sepsis. Br J Nutr 2010, 103:890-898.
26. Condell RA, Tappel AL: Evidence for suitability of glutathione peroxidase as a protective enzyme: studies of oxidative damage, renaturation, and proteolysis. Arch Biochem Biophys 1983, 223:407-416.
27. Blum J, Fridovich I: Inactivation of glutathione peroxidase by superoxide radical. Arch Biochem Biophys 1985, 240:500-508.
28. Shi MM, Kugelman A, Iwamoto T, Tian L, Forman HJ: Quinone-induced oxidative stress elevates glutathione and induces g-glutamylcysteine synthetase activity in rat lung epithelial L2 cells. J Biol Chem 1994, 269:26512-26517.
29. Cho S, Hazama M, Urata Y, Goto S, Horiuchi S, Sumikawa K, Kondo T: Protective role of glutathione synthesis in response to oxidized low density lipoprotein in human vascular endothelial cells. Free Radic Biol Med 1999, 26:589-602.
30. Alhazzani W1, Jacobi J, Sindi A, Hartog C, Reinhart K, Kokkoris S, Gerlach H, Andrews P, Drabek T, Manzanares W, Cook DJ, Jaeschke RZ: The effect of selenium therapy on mortality in patients with sepsis syndrome: a systematic review and meta-analysis of randomized controlled trials. Crit Care Med 2013, 41:1555-1564.
31. Manzanares W, Dhaliwal R, Jiang X, Murch L, Heyland DK: Antioxidant micronutrients in the critically ill: a systematic review and meta-analysis. Crit Care 2012, 16:R66.
32. Huang TS, Shyu YC, Chen HY, Lin LM, Lo CY, Yuan SS, Chen PJ: Effect of parenteral selenium supplementation in critically ill patients: a systematic review and meta-analysis. PLoS One 2013, 8:e54431.
33. Landucci F, Mancinelli P, De Gaudio AR, Virgili G: Selenium supplementation in critically ill patients: a systematic review and meta-analysis. J Crit Care 2014, 29:150-156.
34. Forceville X, Laviolle B, Annane D, Vitoux D, Bleichner G, Korach JM, Cantais E, Georges H, Soubirou JL, Combes A, Bellissant E: Effects of high doses of selenium, as sodium selenite, in septic shock: a placebo-controlled, randomized, double-blind, phase II study. Crit Care 2007, 11:R73.
35. Andrews PJ, Avenell A, Noble DW, Campbell MK, Croal BL, Simpson WG, Vale LD, Battison CG, Jenkinson DJ, Cook JA, Scottish Intensive care Glutamine or seleNium Evaluative Trial Trials Group: Randomised trial of glutamine, selenium, or both, to supplement parenteral nutrition for critically ill patients. BMJ 2011, 342:d1542.
36. Heyland D1, Muscedere J, Wischmeyer PE, Cook D, Jones G, Albert M, Elke G, Berger MM, Day AG, Canadian Critical Care Trials Group: A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med 2013, 368:1489-1497.
37. Reagan-Shaw S, Nihal M, Ahmad N: Dose translation from animal to human studies revisited. FASEB J 2008, 22:659-661.
38. Center for Drug Evaluation and Research: Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers. Rockville, IL: Food and Drug Administration; 2005.